Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD

@article{Myer2018PharmacogeneticsPO,
  title={Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD},
  author={Nicole Myer and J R Boland and Stephen V Faraone},
  journal={Molecular Psychiatry},
  year={2018},
  volume={23},
  pages={1-8}
}
Stimulant medication has long been effective in treating attention-deficit/hyperactivity disorder (ADHD) and is currently the first-line pharmacological treatment for children. Both methylphenidate and amphetamine modulate extracellular catecholamine levels through interaction with dopaminergic, adrenergic and serotonergic system components; it is therefore likely that catecholaminergic molecular components influence the effects of ADHD treatment. Using meta-analysis, we sought to identify… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 77 references

Association of the GRIN2B rs2284411 polymorphism with methylphenidate response in attentiondeficit/hyperactivity disorder

JI Kim, Kim J-W, +3 authors Han D-H
J Psychopharmacol • 2017

Recent Trends in Stimulant Usage.

Journal of attention disorders • 2016

Similar Papers

Loading similar papers…